Men's Health
News from the FDA/CDC
Prostate cancer drug shortage leaves some with uncertainty
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Feature
Older men more at risk as dangerous falls rise for all seniors
“We always hear about lower bone density rates among females, so we didn’t expect to see males with more skull fractures.”
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Conference Coverage
Digital rectal exam fails as screening tool for prostate cancer
In a new study, 99% of digital rectal examinations did not raise suspicion for prostate cancer.
Conference Coverage
Urine test predicts future bladder cancer 12 years before symptoms
The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
Commentary
Three surprising studies on exercise restriction and an exercise sweet spot
New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.
Photo Rounds
Catheterized urine color change
What caused the abrupt change in color of catheterized urine after several days of Foley catheter placement?
Latest News
USPSTF recommends against routine herpes screening for asymptomatic teens and adults
The updated recommendation confirms that harms outweigh benefits for population-based genital HSV screening.
From the Journals
Can a hormone shot rescue low libido?
Two studies provide proof of concept for the development of kisspeptin-based therapeutics for men and women with distressing hypoactive sexual...
Feature
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.